APA (7th ed.) Citation

F, H., G, A., S, N., B, Z., T, F., & MN, H. (2018). Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. Dove Medical Press.

Chicago Style (17th ed.) Citation

F, Haghiralsadat, Amoabediny G, Naderinezhad S, Zandieh-Doulabi B, Forouzanfar T, and Helder MN. Codelivery of Doxorubicin and JIP1 SiRNA with Novel EphA2-targeted PEGylated Cationic Nanoliposomes to Overcome Osteosarcoma Multidrug Resistance. Dove Medical Press, 2018.

MLA (8th ed.) Citation

F, Haghiralsadat, et al. Codelivery of Doxorubicin and JIP1 SiRNA with Novel EphA2-targeted PEGylated Cationic Nanoliposomes to Overcome Osteosarcoma Multidrug Resistance. Dove Medical Press, 2018.